Abstract
This study is rooted in the research traditions of cultivation theory, construct accessibility, and availability heuristic. Based on a survey with 221 subjects, this study finds that familiarity with direct-to-consumer (DTC) print advertisements for antidepressant brands is associated with inflated perceptions of the prevalence and lifetime risk of depression. The study concludes that DTC advertising potentially has significant effects on perceptions of depression prevalence and risk. Interpersonal experiences with depression coupled with DTC advertising appear to significantly predict individuals’ perceived lifetime risk of depression. The study ultimately demonstrates that DTC advertising may play a role in constructing social reality of diseases and medicine. The findings strongly suggest that the social cognitive effects of DTC advertising are far-reaching, impacting pharmaceutical marketing strategy as well as presenting issues regarding public health and the business ethics of advertising drugs to consumers.
Similar content being viewed by others
References
Allison-Ottey S., Ruffin K., Allison K., Ottey C. C. 2003 Assessing the impact of direct-to-consumer advertisements on the AA patient: A multitude survey of patients during the office visit. Journal of the National Medical Association 95(2):120–131
Altshuler L. L., Hendrick V., Burt V. K. 1998 Mood Disorders. In: Wallis L. A. (ed.) Textbook of Women’s Health. Lippincott-Raven Publishers, Philadelphia, PA
An, S.: 2007, ‚Antidepressant Direct-to-Consumer Advertising and Social Perception on the Prevalence of Depression: Application of the Availability Heuristic’, Health Communication (forthcoming)
American Psychiatric Association 1994 Diagnostic and Statistical Manual of Mental Disorders IV. American Psychiatric Association, Washington, D.C
Bell R. A., Kravitz R. L., Wilkes M. S. 1999 Advertisement-induced prescription drug requests: Patients’ anticipated reactions to a physician who refuses. The Journal of Family Practice 48(6):446–452
Bell R. A., Wilkes M. S., Kravitz R. L. 2000 The educational value of consumer-targeted prescription drug print advertising. The Journal of Family Practice 49(12):1092–1098
Beltramini R. F. 2006 Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs. Journal of Business Ethics 63:333–343
Blankenhorn K., Duckwitz N., Kerr M. 2001 Power to the people. Medical Marketing & Media 36(8):66–70
Block L. G., Keller P. A. 1998 Beyond protection motivation: An investigative theory of health appeals. Journal of Applied Social Psychology 28(17):1584–1608
Brichacek, A. and L. J. Sellers: 2001, ‚Flexing Their Budgets: Big Pharma Spend Trends’, Pharmaceutical Executive. http://www.pharmaportal.com/articles/pe/pe0901_sellers. pdf
Calfee J. E. 2002 Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing 21(2):174–193
Condry J. C. 1989 The Psychology of Television. Lawrence Erlbaum, Hillsdale, NJ
Coney S. 2002 Direct-to-consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. Journal of Public Policy and Marketing 22(2):213–223
Davis J. J. 2000 Riskier than we think? The relationship between risk statement completeness and perceptions of direct-to-consumer advertised prescription drugs. Journal of Health Communication 5:349–369
Donohue J. M., Berndt E. R. 2004 Effects of direct-to-consumer advertising on medication choice: The case of anti-depressants. Journal of Public Policy & Marketing 23(2):115–127
Donohue J. M., Berndt E. R., Rosenthal M., Epstein A. M., Frank R. G. 2004 Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care 42(12):1176–1185
Elliott C. 2003 Better than Well: American Medicine Meets the American Dream. W.W. Norton, New York
Findlay S. D. 2001 Direct-to-consumer promotion of prescription drugs: Economic implications for patients, payers, and providers. PharmacoEconomics 19(2):109–119
Gerbner G., Gross L., Jackson-Beeck M., Jeffries-Fox S., Signorielli N. 1978 Violence profile no. 9. Journal of Communication 28:176–207
Gerbner G., Gross L., Morgan M., Signorielli N. 1980 The “mainstreaming” of America: Violence profile no. 11. Journal of Communication 30:10–29
Gerbner G., Gross L., Signorielli N., Morgan M., Jackson-Beeck M. 1979 The demonstration of power: Violence profile no. 10. Journal of Communication 29:177–196
Gilman S. E., Kawachi I., Fitzmaurice G. M., Buka S. L. 2003 Socio-economic status, family disruption and residential stability in childhood: Relation to onset, recurrence and remission of major depression. Psychological Medicine 33(8):1341–1355
Hawkins R. P., Pingree S. 1980 Some processes in the cultivation effect. Communication Research 7:193–226
Hawkins S. A., Hoch S. J. 1992 Low-involvement learning: Memory without evaluation. Journal of Consumer Research 19:212–225
Herzenstein M., Misra S., Posavac S. S. 2005 How consumers’ attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters 15(4):201–212
Higgins, E. T. and G. King: 1981, ‹Accessibility and Applicability: Some “Activation Rules” Influencing Judgement’, Journal of Experimental Social Psychology 31, 218–243
Higgins, E. T., W. S. Rholes and C. R. Jones: 1977, ‹Category Accessibility and Impression Formation’, Journal of Experimental Social Psychology 13, 141–154
Holmer A. F. 1999 Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of American Medical Association 281(4):380–382
Holmer A. F. 2002 Direct-to-consumer advertising – Strengthening our health care system. New England Journal of Medicine 346:526–528
Hollon M. F. 2004 Direct-to-consumer marketing of prescription drugs: A current perspective for neurologists and psychiatrists. CNS Drugs 18(2):69–77
Iizuka T., Jin G. Z. 2005 The effect of prescription drug advertising on doctor visits. Journal of Economics & Management Strategy 14(3):701–727
Irwin K. L., Valdiserri R. O., Holmberg S. D. 1996 The acceptability of voluntary HIV antibody testing in the United States: A decade of lessons learned. AIDS 10(14):1707–1717
John D. R. 1999 Consumer socialization of children: A retrospective look at twenty-five years of research. Journal of Consumer Research 26:183–213
Kalichman S. C., Cain D. 2005 Perceptions of local HIV/AIDS prevalence and risks for HIV/AIDS and other sexually transmitted infections: Preliminary study of intuitive epidemiology. Annals of Behavioral Medicine 29(2):100–105
Kessler R. C., Avenevoli S., Merikangas K. R. 2001 Mood disorder in children and adolescents: An epidemiologic perspective. Biological Psychiatry 49:1002–1014
Kessler R. C., McGonagle K. A., Swartz M., D. Blazer G., Nelson C. B. 1993 Sex and depression in the national comorbidity survey I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders 29:85–96
Kessler R. C., McGonagle K. A., Zhao S. 1994 Lifetime and 12-month prevalence of DSM-Ш psychiatric disorders in the United States: Results from the national comorbidity study. Archives of General Psychiatry 51:8–19
Kornstein, S. G. and B. A. Wojcik: 2002, ‹Depression’, in␣S.␣G. Kornstein and A. H. Clayton (eds.), Women's Mental Health: A Comprehensive Textbook (Guilford Press, New York), pp. 147–165
Kravitz R. L. 2000 Direct-to-consumer advertising of prescription drugs. Western Journal of Medicine 173:221–222
Kravitz R. L., Epstein R. M., Feldman M. D., Franz C. E., Azari R., Wilkes M. S., Hinton L., Franks P. 2005 Influence of patients’ requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association 293(16):1995–2002
Lichter, S. R., L. S. Lichter and S. Rothman: 1994, Prime Time: How TV Portrays American Culture (Regnery, Washington, DC)
Mediamark 2002 http://www.marquette.edu/library/ research/descriptions/mediamark.html
Mehta A., Purvis S. 2003 Consumer responses to print prescription drug advertising. Journal of Advertising Research 43(2):194–206
Menon G., Raghubir P. 2003 Ease-of-retrieval as an automatic input in judgments: A mere-accessibility framework. Journal of Consumer Research 30:230–243
Mintzes B., Barer M. L., Kravitz R. L., Kazanjian A., Bassett K., Lexchin J., Evans R. G., Pan R., Marion S. A. 2002 Influence of direct-to-consumer pharmaceutical advertising and patients’ requests on prescribing decisions: Two site cross-sectional survey. British Medical Journal 324(7332):278–279
Morgan C., Levy D. 1998 To their health. Brandweek 39:30–33
National Comorbidity Survey (NCA): 2003, ‚Lifetime Prevalence of DSM-IV/WMH-CIDI Disorders by Sex and Cohort’, http://www.hcp.med.harvard.edu/ncs/ftpdir/table_ncsr_by_gender_and_age.pdf (Accessed in January, 2007)
National Institute for Health Care Management Research and Education Foundation (NIHCM): 2001, ‚Prescription Drugs and Mass Media Advertising 2000’, www.nihcm.org (Accessed in November, 2006)
National Institute of Mental Health (NIMH): 2000, Depression, http://www.nimh.nih.gov/publicat/nimhdepression.pdf (Accessed in November, 2006)
O’Guinn T. C., Shrum L. J. 1997 The role of television in the construction of consumer reality. Journal of Consumer Research 23:278–294
Perri M., Dickson W. M. 1988 Consumer reaction to a direct-to-consumer prescription drug advertising campaign. Journal of Health Care Marketing 8(2):66–69
Potter W. J. 1993 Cultivation theory and research: A conceptual review. Human Communication Research 19(4):564–601
Putsis W. P., Dhar R. 2001 An empirical analysis of the determinants of category expenditure. Journal of Business Research 52(3):277–291
Pharmaceutical Research Manufacturers of America (PhRMA): 2005, ‚PhRMA Guiding Principles: Direct to Consumer Advertisements About Prescription Medicines’, http://www.phrma.org/files/DTCGuidingprinciples.pdf (Accessed in January, 2007)
Raghubir P., Menon G. 1998 AIDS and Me, never the twain shall meet: the effects of information accessibility on judgments of risk and advertising effectiveness. Journal of Consumer Research 25:52–63
Regier D. A., Narrow W. E., Rae D. S., Manderscheid R. W., Locke B. Z., Goodwin F. K. 1993 Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 50(2):85–94
Rosenthal M. B., Berndt E. R., Donohue J. M., Frank R. G., Epstein A. M. 2002 Promotion of prescription drugs to consumers. New England Journal of Medicine 346(7):498–505
Roskos-Ewoldsen, D. R. and R. H. Fazio: 1997, ‹The Role of Belief Accessibility in Attitude Formation’, The Southern Communication Journal 62, 107–116
Shapiro M. A. 1991 Memory and decision process in the construction of social reality. Communication Research 18:3–24
Sherman S. J., Corty E. 1984 Cognitive Heuristics. In: Wyer R. S., Srull T. K. (eds.) Handbook of Social Cognition, vol. 1. Lawrence Erlbaum, Hillsdale, NJ, pp. 189–286
Shrum L. J. 1996 Psychological processes underlying cultivation effects-Further tests of construct accessibility. Human Communication Research 22:482–509
Shrum L. J. 2003 Media exposure and exemplar accessibility. Media Psychology 5(3):255–282
Shrum L. J., Bischak V. D. 2001 Mainstreaming, resonance, and impersonal impact: Testing moderators of the cultivation effect for estimates of crime risk. Human Communication Research 27(2):187–215
Shrum L. J., O’Guinn T. C. 1993 Processes and effects in the construction of social reality: Construct accessibility as an explanatory variable. Communication Research 20(3):436–471
Siegal K., Raveis V. H., Gorey E. 1998 Barriers and pathways to testing among HIV-infected women. AIDS Education and Prevention 10(2):114–127
Singh N., Kwon I. W., Pereira A. 2003 Cross-cultural consumer socialization: An exploratory study of socialization influences across three ethnic groups. Psychology & Marketing 20(10):867–881
Stroman C. A., Seltzer R. 1985 Media use and perceptions of crime. Journalism Quarterly 62:340–345
Sumpradit, N., Fors S. W., McCormick L. 2002 Consumers’ attitudes and behavior -toward prescription drug advertising. American Journal of Health Behavior 26(1), 68–75
Taylor, S. E., Fiske S. T. 1978 Salience, Attention, and Attribution: Top of the Head Phenomenon. In: L. Berkowitz (eds.) Advances in Experimental Social Psychology vol. 3 Academic Press: New York
Teinowitz, I.: 2003, ‚DTC Ads Become Issue in Race for Democratic Nomination’, Advertising Age 74(42), p. 8
Thomaselli, R.: 2006, ‹Selling Drugs: Glaxo's Crafty Plan’, Advertising Age 77(8), 1–21
Tversky A., Kahneman D. 1973 Availability: A heuristic for judging frequency and probability. Cognitive Psychology 5:207–232
Tybout A. M., Sternthal B., Malaviya P., Bakamitsos G. A., Park S. 2005 Information accessibility as a moderator of judgments: The role of content versus retrieval ease. Journal of Consumer Research 32:76–85
U.S. General Accounting Office 2003 Prescription drugs: FDA oversight of direct-to-consumer drug advertising has limitations. U.S. General Accounting Office, Washington, DC
Weiss G. L., Lonnquist L. E. 1997 The Sociology of Health, Healing, and Illness. Prentice-Hall Inc., Upper Saddle River, NJ
Woo H. J., Dominick J. R. 2003 Acculturation, cultivation, and daytime TV talk shows. Journalism and Mass Communication Quarterly 80(1):109–127
Wyer R. S., Srull T. K. 1989 Memory and Cognition in its Social Context. Lawrence Erlbaum, Hillside, NJ
Zachry W. M., Shepherd M. D., Hinich M. J., Wilson J. P., Brown C. M., Lawson K. A. 2002 Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. American Journal of Health-System Pharmacy 59:42–49
Acknowledgements
The authors thank the anonymous reviewers for their insightful comments. An early draft of this manuscript was presented at the 2006 annual convention for Association for Education in Journalism and Mass Communication.
Author information
Authors and Affiliations
Corresponding author
Additional information
Jin Seong Park is a doctoral student at the University of Florida in Gainesville. He earned his MA from Marquette University and BA from Korea University in Seoul, Korea. His research interests include health communication and DTC drug advertising, mood and heuristics in consumer information processing and judgments, and international advertising.
Jean M. Grow is an assistant professor at Marquette University. She earned her PhD from University of Wisconsin-Madison and her BFA from the School of Art Institute of Chicago. Her scholarly work focuses on controversial advertising case studies. She has published extensively on Nike women's advertising, and her most recent scholarship focuses on DTC advertising of pharmaceuticals and public service announcements for Hepatitis C. In 2005, she coauthoured a book on creative strategy, Advertising Strategy: Creative Tactics from Outside/In (with T. Altstiel). Prior to joining the academy, she worked in the advertising industry with agencies such as DDB Needham, Foote Cone & Belding, J. Walter Thompson, and Leo Burnett.
Rights and permissions
About this article
Cite this article
Park, J.S., Grow, J.M. The Social Reality of Depression: DTC Advertising of Antidepressants and Perceptions of the Prevalence and Lifetime Risk of Depression. J Bus Ethics 79, 379–393 (2008). https://doi.org/10.1007/s10551-007-9403-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10551-007-9403-7